Our Life Sciences Markets

What does being a global life sciences company mean to MDS?

For MDS, being a global life sciences company means being a leading innovator in the high-growth life sciences markets we serve. It means achieving this through quality products and services and unmatched customer relationships, scientific leadership and global management talent. Being a successful life sciences company means maintaining our single-minded focus: improving the health and well being of people all around our world.

MDS Analytical Technologies MDS Nordion MDS Pharma Services
  • A global leader providing innovative tools for life sciences research and drug discovery and development.
  • Sciex brand offers proven market leadership in mass spectrometry
  • Molecular Devices brand is the gold standard in high-performance bioanalytical measurement systems
  • A global leader in supplying medical isotopes for molecular imaging
  • Leading provider of sterilization technologies for disease prevention and radiotherapeutics for targeted cancer treatments
  • A global leader in contract manufacturing for the radiotherapeutics industry
  • A global leader in delivering high-quality on-time contract research services at each stage of the drug discovery and development process
  • Value-added services help to bring new drugs to market safely and efficiently

Market Size

Market Growth

$6 billion

6% - 10%

Market Size

Market Growth

$4 billion

5% - 7%

Market Size

Market Growth

$15 billion

10% - 13%

2007 Net Revenue

$352 million

 31% of total revenues

2007 Net Revenue

$290 million

 26% of total revenues

2007 Net Revenue

$477 million

43% of total revenues

Market Segments

  • Life Sciences Mass Spectrometers
  • Drug Discovery
  • BioResearch

Market Segments

  • Medical Imaging Isotopes
  • Radiotherapeutics Products
  • Sterilization Technologies

Market Segments

  • Early-Stage
  • Late-Stage